MEDIA_REFRESH_DATA_PRESS_RELEASE
Media
U.S. News Room
Press Releases
Thu Mar 28 00:00:00 GMT-05:00 2019
Daiichi Sankyo and AstraZeneca Announce Global Development and Commercialization Collaboration for Daiichi Sankyo’s HER2 Targeting Antibody Drug Conjugate [Fam-] Trastuzumab Deruxtecan (DS-8201)
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Thu Mar 28 00:00:00 GMT-05:00 2019
Daiichi Sankyo Confirms Plans to Accelerate BLA Submission to U.S. FDA for [Fam-] Trastuzumab Deruxtecan (DS-8201) in HER2 Positive Metastatic Breast Cancer Post T-DM1
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Fri Feb 22 00:00:00 GMT-05:00 2019
Daiichi Sankyo Shifts Several Top Leaders to New Roles for Company’s Launch into its Next Growth Phase
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Tue Feb 05 00:00:00 GMT-05:00 2019
FDA Grants Priority Review for Daiichi Sankyo’s New Drug Application for CSF1R Inhibitor Pexidartinib for Treatment of Patients with TGCT, a Rare, Debilitating Tumor
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)
Tue Jan 29 00:00:00 GMT-05:00 2019
Carrie Ann Inaba Partners with Daiichi Sankyo, Inc. to Encourage Americans to “Get Iron Informed”
![](https://daiichisankyo.us/o/dsi-new-theme/images/icn-pdf.png)